Skip to content

Dementia Australia grants more than $320,000 to diverse community group

By API User

Dementia Australia has today announced the recipients of its inaugural Diversity Small Grant program, awarding more than $320,000 to 11 Aboriginal, Torres Strait Islander and culturally and linguistically diverse (CALD) community groups and organisations across Australia.      Each of the 11 recipients were awarded up to $30,000 each to fund activities focused on building … Continued

NEXSEN Biotech: Revolutionising Global Diagnostics with Nano-Technology Solutions

By API User

Sydney, Australia – 11 December, 2024 | NEXSEN Biotech Pty Ltd (“NEXSEN”) is setting a new standard in the diagnostic landscape with its innovative point-of-care (POC) testing solutions. Leveraging state-of-the-art nano-biotechnology, NEXSEN is addressing critical gaps in global healthcare by providing fast, accurate, and affordable diagnostic tools.   StrepSure® – Innovative Solutions for Unmet Medical Needs  … Continued

Solving clinical problems by thinking in three dimensions

By API User

Biomedical engineers at UNSW Sydney have their sights on developing anatomically accurate 3D printed models which mimic exactly the way body parts feel and move. The ambitious plans come after researchers at the Tyree Foundation Institute of Health Engineering (IHealthE) recently designed and created a patient-based anatomical 3D model of a young child’s skull which … Continued

ACN collaboration with Ugandan nurses and midwives

By API User

Mothers in Uganda will benefit from safer, higher-quality care during childbirth, thanks to a local initiative supported by the Australian College of Nursing (ACN).   As part of the ODENNA Africa Project, led by the International Council of Nurses (ICN), ACN is mentoring and sharing knowledge with the Uganda Nurses and Midwives Union (UNMU) to … Continued

Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus

By API User

Orthogon’s small molecule therapeutics redefine treatment possibilities for BK virus infections. CANTON, Mass.–BUSINESS WIRE– Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing total funding to over $25M. This funding will accelerate the development of its first-in-class treatments for managing BK … Continued

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

By API User

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine’s … Continued

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets

By API User

5-year follow-up from SEQUOIA study demonstrated treatment with BRUKINSA reduced the risk of progression or death by 71% compared to bendamustine-rituximab in patients with treatment-naïve CLL, further solidifying its position as the leader in new patient starts in both frontline and relapsed/refractory (R/R) CLL with the broadest label of any BTK inhibitor At a median … Continued

ReNerve Limited Partners with Union MediScience to Expand Middle East Operations

By API User

Melbourne, Australia – 10 December 2024 | ReNerve Limited (ASX:RNV, “ReNerve” or “the Company”) is pleased to announce an exclusive distribution partnership with Union MediScience B.S.C (“Union MediScience”), one of the leading medical device distributors in the Middle East region. This agreement will facilitate the sales and marketing efforts for ReNerve’s flagship product, the NervAlign® … Continued